SuperworthIndaptus Therapeutics shares outstanding INDP
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 116.1M
- On a year earlier
- +20099.4%
- more shares
Indaptus Therapeutics had 116.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 20099.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.8M | +359% |
| FY2024 | 389.8K | +30% |
| FY2023 | 300K | +2% |
| FY2022 | 295.4K | +0% |
| FY2021 | 294.2K | +324% |
| FY2020 | 69.5K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 116.1M | +20099% | |
| Q1 FY26 | 11M | +2101% | |
| Q4 FY25 | 1.8M | +359% | |
| Q3 FY25 | 997K | +194% | |
| Q2 FY25 | 574.9K | +88% | |
| Q1 FY25 | 497.8K | +65% | |
| Q4 FY24 | 389.8K | +30% | |
| Q3 FY24 | 339.7K | +13% | |
| Q2 FY24 | 305.1K | +2% | |
| Q1 FY24 | 301.5K | +0% | |
| Q4 FY23 | 300K | +2% | |
| Q3 FY23 | 300K | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Indaptus Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.